Engineering high‐affinity dual targeting cellular nanovesicles for optimised cancer immunotherapy

Dual targeting to immune checkpoints has achieved a better therapeutic efficacy than single targeting due to synergistic extrication of tumour immunity. However, most dual targeting strategies are usually antibody dependent which facing drawbacks of antibodies, such as poor solid tumour penetration...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Luyao, Zhao, Xu, Niu, Yanan, Ma, Xiaoya, Yuan, Wei, Ma, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654473/
https://www.ncbi.nlm.nih.gov/pubmed/37974395
http://dx.doi.org/10.1002/jev2.12379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654473/
https://www.ncbi.nlm.nih.gov/pubmed/37974395
http://dx.doi.org/10.1002/jev2.12379

Ejemplares similares